Over the past several decades, biopharmaceutical technology has experienced tremendous growth. Increased research in biologics has led to the development of new drugs and therapeutics, further increasing our arsenal to fight disease. However, the use of biological materials in pharmaceutical manufacturing requires a comprehensive virus clearance service to ensure process validation, removal of viral contamination, and patient safety. In this webinar, Kelly Burningham, Study Director III in Virology, discusses the importance of viral clearance within biopharmaceutical manufacturing. She will cover the various approaches and considerations employed within a comprehensive viral clearance study to ensure the safety of biological products.

Highlights

• Viral Clearance Process Validation
• Blood Product Considerations
• Viral Safety – GMP Screening for Lot Release
• Viral Disinfectant Validation